Developing Immunoniosomes (INs): Antibody and Fab conjugations of niosomal nanoparticles via UV-NBS and EDC/NHS chemistry for treating glioblastoma cells

Antibody-conjugated nanoparticles (ACNPs), particularly immunoliposomes (ILs), have gained significant attention in cancer treatment due to their enhanced efficacy and superior tissue penetration. However, their high production costs and technical challenges underscore the need for more cost-effecti...

Full description

Saved in:
Bibliographic Details
Main Authors: Nilufer Cakir, Hatice Oncel, Aylin Ozkan, Dilan Bicak, Sibel Akgun Bas, Nur Mustafaoglu
Format: Article
Language:English
Published: Elsevier 2025-12-01
Series:International Journal of Pharmaceutics: X
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2590156725000520
Tags: Add Tag
No Tags, Be the first to tag this record!